Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Comparative Effectiveness “Infrastructure” Could Get Discretionary Funding

Executive Summary

The $400 million discretionary fund for comparative effectiveness research to be administered by the secretary of Health and Human Services might not be used for research at all

You may also be interested in...



Comparative Effectiveness Council Urges Infrastructure Improvements

Federal Coordinating Council for Comparative Effectiveness Research also recommends HHS money focus on dissemination of research results.

HHS Secretary-Nominee Sebelius Hearings Set Before Senate Health, Finance Committees

Rapid succession of hearings (March 31 and April 2) suggests smooth path to confirmation.

AHRQ’s Clancy, OMB’s Emanuel Key Figures On Comparative Research Cmte.

The Federal Coordinating Committee on Comparative Effectiveness Research includes Agency for Health Care Research & Quality Administrator Carolyn Clancy and Office of Management & Budget Special Advisor Ezekiel Emanuel

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS050873

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel